Exact Mass: 1060.5481
Exact Mass Matches: 1060.5481
Found 183 metabolites which its exact mass value is equals to given mass value 1060.5481
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pacific Ciguatoxin 4A
Pacific Ciguatoxin 4A is found in fishes. Pacific Ciguatoxin 4A is isolated from Gambierdiscus toxicus and Scarus gibbus. Pacific Ciguatoxin 4A is a toxin isolated from various parrotfish (Scarus sp.) and named *Scaritoxin* or *SG 1* probably corresponds to a mixture of CTX 4A and 4B. Isolated from Gambierdiscus toxicus and Scarus gibbus. A toxin isolated from various parrotfish (Scarus species) and named *Scaritoxin* or *SG 1* probably corresponds to a mixture of CTX 4A and 4B. Pacific Ciguatoxin 4A is found in fishes. D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins
Pitheduloside K
Pitheduloside K is found in fruits. Pitheduloside K is a constituent of Pithecellobium dulce (manila tamarind) Constituent of Pithecellobium dulce (manila tamarind). Pitheduloside K is found in fruits.
Medicoside I
Medicoside I is found in pulses. Medicoside I is isolated from Medicago sativa (alfalfa). Isolated from Medicago sativa (alfalfa). Medicoside I is found in pulses.
Dulcin
Dulcin is found in fruits. Dulcin is a constituent of Pithecellobium dulce (manila tamarind). Constituent of Pithecellobium dulce (manila tamarind). Dulcin is found in fruits.
Ardisiacrispin A
Ardisiacrispin A (Deglucocyclamin) is a common triterpenoid saponin from Ardisia species. Ardisiacrispin A has similar biological properties with some triterpenoid saponins in A. crenata which is one of the species of genus Ardisia and exhibits cytotoxic effect on tumor cells, immunomodulatory and antiviral activities[1]. Ardisiacrispin A (Deglucocyclamin) is a common triterpenoid saponin from Ardisia species. Ardisiacrispin A has similar biological properties with some triterpenoid saponins in A. crenata which is one of the species of genus Ardisia and exhibits cytotoxic effect on tumor cells, immunomodulatory and antiviral activities[1].
PIP(20:0/6 keto-PGF1alpha)
PIP(20:0/6 keto-PGF1alpha) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:0/6 keto-PGF1alpha), in particular, consists of one chain of eicosanoyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.
PIP(6 keto-PGF1alpha/20:0)
PIP(6 keto-PGF1alpha/20:0) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(6 keto-PGF1alpha/20:0), in particular, consists of one chain of 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of eicosanoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.
PIP(20:0/TXB2)
PIP(20:0/TXB2) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:0/TXB2), in particular, consists of one chain of eicosanoyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.
PIP(TXB2/20:0)
PIP(TXB2/20:0) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(TXB2/20:0), in particular, consists of one chain of Thromboxane B2 at the C-1 position and one chain of eicosanoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.
PIP(22:3(10Z,13Z,16Z)/PGJ2)
PIP(22:3(10Z,13Z,16Z)/PGJ2) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:3(10Z,13Z,16Z)/PGJ2), in particular, consists of one chain of 10Z,13Z,16Z-docosenoyl at the C-1 position and one chain of Prostaglandin J2 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.
PIP(PGJ2/22:3(10Z,13Z,16Z))
PIP(PGJ2/22:3(10Z,13Z,16Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(PGJ2/22:3(10Z,13Z,16Z)), in particular, consists of one chain of Prostaglandin J2 at the C-1 position and one chain of 10Z,13Z,16Z-docosenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.
Ardisiacrispin A
(1S,2R,4S,5R,8R,13R,14R,17S,18R,20S)-10-[(2S,3R,4S,5S)-5-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2-hydroxy-4,5,9,9,13,20-hexamethyl-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracosane-20-carbaldehyde is a natural product found in Ardisia crenata and Androsace integra with data available. Ardisiacrispin A (Deglucocyclamin) is a common triterpenoid saponin from Ardisia species. Ardisiacrispin A has similar biological properties with some triterpenoid saponins in A. crenata which is one of the species of genus Ardisia and exhibits cytotoxic effect on tumor cells, immunomodulatory and antiviral activities[1]. Ardisiacrispin A (Deglucocyclamin) is a common triterpenoid saponin from Ardisia species. Ardisiacrispin A has similar biological properties with some triterpenoid saponins in A. crenata which is one of the species of genus Ardisia and exhibits cytotoxic effect on tumor cells, immunomodulatory and antiviral activities[1].
Dioscoreside C
3-O-beta-D-xylopyranosyl(1[*]2)-[beta-D-glucopyranosyl(1[*]3)]-alpha-L-arabinopyranosyl 27-hydroxy oleanolic acid 28-O-beta-D-glucopyranoside
3-O-??-D-Glucopyranosyl-(1鈥樏傗垎4)-??-D-fucopyranosyl (22S,24Z)-cycloart-24-en-3??,22,26-triol 26-O-??-L-arabinopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside|3-O-??-D-Glucopyranosyl-(1鈥樏傗垎4)-??-D-fucopyranosyl (22S,24Z)-cycloart-24-en-3??,22,26-triol 26-O-??-D-xylopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
(23S)-17??,23-Epoxy-29-hydroxy-3??-[(O-??-L-rhamnopyranosyl-(1鈥樏傗垎2)-O-??-D-glucopyranosyl-(1鈥樏傗垎2)-O-??-L-arabinopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranosyl)oxy]-27-norlanost-8-en-24-one
(23S,24S,25S)-23,24-dihydroxyruscogenin 1-O-2)> 3)>-alpha-L-arabinopyranoside 24-O-beta-D-fucopyranoside|(23S,24S,25S)-23,24-dihydroxyruscogenin 1-O-[alpha-L-4-O-acetylrhamnopyranosyl(1->2)] [beta-D-xylopyranosyl(1->3)]-alpha-L-arabinopyranoside 24-O-beta-D-fucopyranoside
jujubogenin 3-O-alpha-L-arabinofuranosyl(1->2)-[beta-D-glucopyranosyl(1->6)-beta-D-glucopyranosyl(1->3)]-alpha-L-arabinopyranoside
(3beta,23E)-21-(beta-D-glucopyranosyloxy)-20-hydroxydammara-23,25-dien-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->2)-[beta-D-xylopyranosyl-(1->3)]-beta-D-glucopyranoside
3beta-O-(beta-D-Xylopyranosyl-(1-3)-alpha-L-arabinopyranosyl)-20beta,23-dihydroxyurs-12-en-28-O-[alpha-L-rhamnopyranosyl-(1-6)-beta-D-glucopyranosyl] ester
3-O-(4beta-D-xylopyranosyl(1-->2) beta-D-glucopyranosyl(1-->4) 2)> alpha-L-arabinopyranosyl)cyclamiretin D|3-O-{4beta-D-xylopyranosyl(1-->2) beta-D-glucopyranosyl(1-->4) [beta-D-glucopyranosyl(1-->2)] alpha-L-arabinopyranosyl}cyclamiretin D
(25R)-26-O-beta-D-glucopyranosyl-3beta,26-dihydroxy-cholesta-5,14,16-trien-22-one-3-O-beta-D-glucopyranosyl-(1?2)-beta-D-glucopyranosyl-(1?4)-beta-D-galactopyranoside|polygonatumoside C
(25R)-3beta-[(alpha-L-rhamnopyranosyl-(1->2)-[alpha-L-rhamnopyranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->4)]-beta-D-glucopyranosyl)oxy]-7alpha,11alpha-dihydroxy-spirost-5-en-12-one|ypsilandroside K
(23R)-3??-[(O-??-D-Apiofuranosyl-(1鈥樏傗垎2)-O-??-D-glucopyranosyl-(1鈥樏傗垎2)-O-??-L-arabinopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranosyl)oxy]-17??,23-epoxy-29-hydroxy-27-norlanost-8-ene-15,24-dione
3-O-beta-D-glucopyranosyl-(1->2)-[alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)]-alpha-L-arabinopyranosyl-13beta,28-epoxy-3beta,16alpha-dihydroxyoleanane|3beta-(O-beta-D-glucopyranosyl-(1?2)-[alpha-L-rhamnopyranosyl-(1?2)-beta-D-glucopyranosyl-(1?4)]-alpha-L-arabinopyranosyl)-13beta,28-epoxy-16alpha-hydroxyoleanane|3beta-O-beta-D-glucopyranosyl-(1->2)-[alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)]-alpha-L-arabinopyranosyl-13beta,28-epoxy-16alpha-hydroxyoleanoane
3-O-beta-D-xylopyranosyl(1[*]2)-[beta-D-glucopyranosyl(1[*]3)]-alpha-L-arabinopyranosyl 27-hydroxyursolic acid 28-O-beta-D-glucopyranoside
3-O-[beta-D-xylopyranosyl(1->2)-alpha-L-arabinopyranosyl]-27-hydroxy-oleanolic acid 28-O-[beta-D-glucopyranosyl(1->6)-beta-D-glucopyranosyl] ester
3-O-{beta-D-glucopyranosyl(1->3)[alpha-L-arabinofuranosyl(1->2)]-beta-D-glucopyranosyl}-20-O-alpha-L-arabinopyranosyl pseudojujubogenin|bacopaside-XII
(25R) 26-O-beta-D-glucopyranosyl-5,20-diene-15-methoxy-3beta,26-dihydroxyfurost-3-O-[alpha-L-rhamnopyranosyl(1->2)][alpha-L-rhamnopyranosyl(1->4)]-beta-D-glucopyranoside|15-methoxy-pseudoprotodioscin
3-O-[beta-D-glucopyranosyl(1->3){alpha-L-arabinofuranosyl(1->2)}beta-D-glucopyranosyl]-20-O-(alpha-L-arabinopyranosyl)jujubogenin|bacopasaponin F
C52H84O22_Olean-12-en-28-oic acid, 3-[[O-beta-D-glucopyranosyl-(1->2)-O-[O-beta-D-xylopyranosyl-(1->2)-alpha-L-arabinopyranosyl-(1->6)]-beta-D-glucopyranosyl]oxy]-16-hydroxy-, (3beta,5xi,9xi,16alpha)
C52H84O22_6-Deoxy-alpha-D-mannopyranosyl-(1->3)-beta-D-xylopyranosyl-(1->4)-6-deoxy-alpha-L-mannopyranosyl-(1->2)-1-O-[(2alpha,3alpha,5xi,6beta,9xi)-2,3,6,23-tetrahydroxy-28-oxoolean-12-en-28-yl]-alpha-L-arabinopyranose
(4aR,5R,6aS,6bR,10S,12aR,14bS)-10-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
(4aR,5R,6aS,6bR,10S,12aR,14bS)-10-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid_25.7\\%
(4aR,5R,6aS,6bR,10S,12aR,14bS)-10-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid_55.8\\%
(4aR,5R,6aS,6bR,10S,12aR,14bS)-10-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid_minor
(4aR,5R,6aS,6bR,10S,12aR,14bS)-10-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid_76.5\\%
(4aR,5R,6aS,6bR,10S,12aR,14bS)-10-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid_99.9\\%
(4aR,5R,6aS,6bR,10S,12aR,14bS)-10-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid_major
(4aR,5R,6aS,6bR,10S,12aR,14bS)-10-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid_43.4\\%
(4aR,5R,6aS,6bR,10S,12aR,14bS)-10-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid_39.7\\%
(4aR,5R,6aS,6bR,10S,12aR,14bS)-10-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid_84.9\\%
Pitheduloside K
Medicoside I
(4aR,5R,6aS,6bR,10S,12aR,14bS)-10-(((2R,3R,4S,5S,6R)-6-((((2S,3R,4S,5S)-4,5-dihydroxy-3-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-4,5-dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,1
ciguatoxin CTX4B
D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D002922 - Ciguatoxins
3-O-[alpha-L-arabinopyranosyl(1->2)-alpha-L-arabinopyranosyl(1->6)-[beta-D-glucopyranosyl(1->2)]-beta-D-glucopyranoside echinocystic acid
A natural product found in Albizia inundata.
3-O-[beta-D-xylopyranosyl(1->2)-alpha-L-arabinopyranosyl(1->6)-[beta-D-glucopyranosyl(1->2)]-beta-D-glucopyranoside echinocystic acid
A natural product found in Albizia inundata.
(3beta,16alpha)-16-hydroxy-13,28-epoxyoleanan-3-yl alpha-L-Rhap-(1->2)-beta-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-alpha-L-arabinopyranoside
A triterpenoid saponin isolated from Myrsine australis and Ardisia japonica and has been shown to exhibit antineoplastic activity.
Pacific Ciguatoxin 4A
D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins
CTX-4B
A ciguatoxin comprising a sequence of twelve trans-fused six-, seven-, eight- and nine-membered oxacycles and a spiro-fused tetrahydrofuran substituted by a (1E)-buta-1,3-dien-1-yl side chain. It is isolated from Gambierdiscus toxicus. D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D002922 - Ciguatoxins
3beta-O-{alpha-L-Rhap-(1->2)-beta-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-alpha-L-Arap}primulagenin A
A triterpenoid saponin that is composed of primulagenin A having a alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-alpha-L-arabinopyranosyl moiety attached to position 3 by a glycosidic linkage. It is isolated from the whole plants of Ardisia pusilla and exhibits cytotoxic activity against human gliboblastoma U251MG cells.
kinetensin (1-8)(2+)
A peptide cation obtained from the deprotonation of the carboxy group of L-phenylalanine residue, and protonation of the amino group of L-isoleucyl and protonation of the side chains of L-arginyl residues of kinetensin (1-8). It is the major species at pH 7.3.
(2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,7r,8s,8ar,9r,10r,12as,14ar,14br)-7,8,9-trihydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-10-[(2-methylbutanoyl)oxy]-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2r,3s,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxane-2-carboxylic acid
(2s,3r,4s,5s,6r)-2-{[(2r,3r,4s,5r,6r)-3-{[(2s,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-2-{[(1s,2r,5r,7s,10r,11r,14r,15s,16s,17r,20r)-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-16-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(2r,3r,4s,5r,6r)-3-{[(2s,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-2-{[(1r,2r,5r,7s,10r,11s,14r,15s,16s,18s,20s)-6,6,10,14,16-pentamethyl-18-(2-methylprop-1-en-1-yl)-16-{[(2r,3s,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,8ar,9s,10r,11r,12as,14ar,14br)-10-hydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-9-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-5-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxyoxane-2-carboxylic acid
5-({4,5-dihydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-3,4-dihydroxy-6-{[10-hydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-9-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}oxane-2-carboxylic acid
(1s,2r,4s,5r,8r,10s,13r,14r,17s,18r,20s)-10-{[(2s,3r,4s,5s)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-hydroxy-4,5,9,9,13,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosane-20-carbaldehyde
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-3,5-dihydroxy-4-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
1-{7-[(6-{[(3-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl)oxy]-6-(hydroxymethyl)-3',3a,6,9a,11a-pentamethyl-2,3,4,5,5a,7,8,9,10,11-decahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-5'-yl}propan-1-one
(2s,3r,4s,5r,6r)-5-hydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-6-({[(2r,3s,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl (4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
7-({6-[({3-[(3-{[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-4,5-dihydroxyoxan-2-yl}oxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)-6-(hydroxymethyl)-3',3a,6,9a,11a-pentamethyl-5'-propanoyl-4,5,5a,7,8,9,10,11-octahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-3-one
16'-{[5-({3,4-dihydroxy-6-methyl-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-4-hydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-11',20'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-10'-one
3-[(4-{[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-6-methyl-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl 10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
2,3,23-trihydroxy-12-oleanen-28-oic acid; (2α,3β)-form,28-o-[alpha-d-arabinopyranosyl-(1→6)-[alpha-l-rhamnopyranosyl-(1→2)]-[beta-d-xylopyranosyl-(1→3)]-beta-d-glucopyranosyl] ester
{"Ingredient_id": "HBIN003816","Ingredient_name": "2,3,23-trihydroxy-12-oleanen-28-oic acid; (2\u03b1,3\u03b2)-form,28-o-[alpha-d-arabinopyranosyl-(1\u21926)-[alpha-l-rhamnopyranosyl-(1\u21922)]-[beta-d-xylopyranosyl-(1\u21923)]-beta-d-glucopyranosyl] ester","Alias": "NA","Ingredient_formula": "C52H84O22","Ingredient_Smile": "NA","Ingredient_weight": "1061.21","OB_score": "NA","CAS_id": "160471-35-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9006","PubChem_id": "NA","DrugBank_id": "NA"}
(23r)-3β-[(o-β-d-apiofuranosyl-(1→2)-o-β-d-glucopyranosyl-(1→2)-o-α-l-arabinopyranos-yl-(1→6)-β-d-glucopyranosyl)oxy]-17α,23-epoxy-29-hydroxy-27-norlanost-8-ene-15,24-dione
{"Ingredient_id": "HBIN004154","Ingredient_name": "(23r)-3\u03b2-[(o-\u03b2-d-apiofuranosyl-(1\u21922)-o-\u03b2-d-glucopyranosyl-(1\u21922)-o-\u03b1-l-arabinopyranos-yl-(1\u21926)-\u03b2-d-glucopyranosyl)oxy]-17\u03b1,23-epoxy-29-hydroxy-27-norlanost-8-ene-15,24-dione","Alias": "NA","Ingredient_formula": "C51H80O23","Ingredient_Smile": "CCC(=O)C1CC(C2(O1)CC(=O)C3(C2(CCC4=C3CCC5C4(CCC(C5(C)CO)OC6C(C(C(C(O6)COC7C(C(C(CO7)O)O)OC8C(C(C(C(O8)CO)O)O)OC9C(C(CO9)(CO)O)O)O)O)O)C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1507","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(23s)-17α,23-epoxy-29-hydroxy-3β-[(o-α-l-rhamnopyranosyl-(1→2)-o-β-d-glucopyra-nosyl-(1→2)-o-α-l-arabinopyranosyl-(1→6)-β-d-glucopyranosyl)oxy]-27-norlanost-8-en-24-one
{"Ingredient_id": "HBIN004157","Ingredient_name": "(23s)-17\u03b1,23-epoxy-29-hydroxy-3\u03b2-[(o-\u03b1-l-rhamnopyranosyl-(1\u21922)-o-\u03b2-d-glucopyra-nosyl-(1\u21922)-o-\u03b1-l-arabinopyranosyl-(1\u21926)-\u03b2-d-glucopyranosyl)oxy]-27-norlanost-8-en-24-one","Alias": "NA","Ingredient_formula": "C52H84O22","Ingredient_Smile": "CCC(=O)C1CC(C2(O1)CCC3(C2(CCC4=C3CCC5C4(CCC(C5(C)CO)OC6C(C(C(C(O6)COC7C(C(C(CO7)O)O)OC8C(C(C(C(O8)CO)O)O)OC9C(C(C(C(O9)C)O)O)O)O)O)O)C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7131","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-o-β-d-glucopyranosyl-(1→4)-β-d-fucopyra-nosyl(22s,24z)-cycloart-24-en-3β,22,26-triol26-o-α-l-arabinopyranosyl-(1→6)-β-d-gluco-pyranoside
{"Ingredient_id": "HBIN009199","Ingredient_name": "3-o-\u03b2-d-glucopyranosyl-(1\u21924)-\u03b2-d-fucopyra-nosyl(22s,24z)-cycloart-24-en-3\u03b2,22,26-triol26-o-\u03b1-l-arabinopyranosyl-(1\u21926)-\u03b2-d-gluco-pyranoside","Alias": "NA","Ingredient_formula": "C53H88O21","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8625","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-o-β-d-glucopyranosyl-(1→4)-β-d-fucopyra-nosyl(22s,24z)-cycloart-24-en-3β,22,26-triol26-o-β-d-xylopyranosyl-(1→6)-β-d-glucopy-ranoside
{"Ingredient_id": "HBIN009201","Ingredient_name": "3-o-\u03b2-d-glucopyranosyl-(1\u21924)-\u03b2-d-fucopyra-nosyl(22s,24z)-cycloart-24-en-3\u03b2,22,26-triol26-o-\u03b2-d-xylopyranosyl-(1\u21926)-\u03b2-d-glucopy-ranoside","Alias": "NA","Ingredient_formula": "C53H88O21","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8628","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
akebiasaponin e
{"Ingredient_id": "HBIN015002","Ingredient_name": "akebiasaponin e","Alias": "NA","Ingredient_formula": "C52H84O22","Ingredient_Smile": "NA","Ingredient_weight": "1061.21","OB_score": "NA","CAS_id": "39524-14-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7084","PubChem_id": "NA","DrugBank_id": "NA"}